Cytokine milieu in renal cavities of immunocompetent mice in response to intravenous challenge of Aspergillus flavus leading to aspergillosis

Cytokine

Volumn 61, Issue 1, 2013, Pages 63-70

  Anand, Rajesh ^a   Shankar, Jata ^b   Singh, Agam P ^c   Tiwary, Bhupendra N ^d  

^a PATNA UNIVERSITY   (India)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^d GURU GHASIDAS UNIVERSITY   (India)

Author keywords

Aspergillus flavus; Blastoconidia; Cytokines; Kidney; Neutrophils

Indexed keywords

AFLATOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CELL TRANSPORT; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS GROWTH; HISTOPATHOLOGY; IMMUNOCOMPETENCE; INNATE IMMUNITY; KIDNEY HOMOGENATE; KIDNEY INFECTION; KIDNEY PELVIS; MACROPHAGE; MALE; MOUSE; NEPHRITIS; NEUTROPHIL; NONHUMAN; PARASITE CLEARANCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TH2 CELL; UPREGULATION; URETER; VIRUS VIRULENCE;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CYTOKINES; KIDNEY; MALE; MICE; MICE, INBRED BALB C; TH2 CELLS;

ASPERGILLUS; ASPERGILLUS FLAVUS; MURINAE; MUS;

EID: 84869888614     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.024     Document Type: Article

References (29)

1. Denning D.W. Invasive aspergillosis. Clin Infect Dis 1993, 26:781-803.
2. Morgan J., Wannemuehler K.A., Marr K.A., Hadley S., Kontoyiannis D.P., Walsh T.J., et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005, 43:S49-S58.
3. Ford S., Friedman L. Experimental study of the pathogenicity of aspergilli for mice. J Bacteriol 1967, 94:928-933.
4. Mosquera J., Warn P.A., Morrissey J., Moore C.B., Gil-Lamaignere C., Denning D.W. Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo. Antimicrob Agents Chemother 2001, 45:1456-1462.
5. Kamai Y., Harasaki T., Fukuoka T., Ohya S., Uchida K., Yamaguchi H., et al. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent. Antimicrob Agents Chemother 2002, 46:367-370.
6. Richard J.L., Thurston J.R., Peden W.M., Pinello C. Recent studies on aspergillosis in Turkey poults. Mycopathologia 1984, 87:3-11.
7. Khairallah S.H., Byrne K.A., Tabbara K.F. Fungal keratitis in Saudi Arabia. Doc Ophthalmol 1992, 79:269-276.
8. Kameswaran M., al-Wadei A., Khurana P., Okafor B.C. Rhinocerebral aspergillosis. J Laryngol Otol 1992, 106:981-985.
9. Mahgoub E.S., el-Hassan A.M. Pulmonary aspergillosis caused by Aspergillus flavus. Thorax 1972, 27:33-37.
10. Rhodes JC. Fungal infections and immune responses. In: Murphy JW, Friedman H, Bendinelli M, editors. US: Springer;1993. p. 359-77.
11. Cenci E., Perito S., Enssle K.H., Mosci P., Latge J.P., Romani L., et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997, 65(1997):564-570.
12. Nagai H., Guo J., Choi H., Kurup V. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 1995, 172:1554-1560.
13. Cenci E., Mencacci A., Fè d'Ostiani C., Montagnoli C., Bacci A., Del Sero G., et al. Cytokine- and T-helper-dependent immunity in murine aspergillosis. Res Immunol 1998, 149:445-454.
14. Cenci E., Mencacci A., Fè d'Ostiani C., Del Sero G., Mosci P., Montagnoli C., et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998, 178:1750-1760.
15. Cenci E., Mencacci A., Del Sero G., Bacci A., Montagnoli C., d'Ostiani C.F., et al. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 1999, 180:1957-1968.
16. Liu M., Clemons K.V., Bigos M., Medovarskad I., Brummera E., Stevens D.A. Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection. Vaccine 2011, 29:1745-1753.
17. Powrie F., Coffman R.L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993, 14:270-274.
18. Anand R., Tiwary B.N. Th1 and Th2 cytokines in a self-healing primary pulmonary Aspergillus flavus infection in BALB/c mice. Cytokine 2010, 52:258-264.
19. Cua Daniel J., Tato Cristina M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10:479-489.
20. Aimanianda V., Bayry J., Bozza S., Kniemeyer O., Perruccio K., et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009, 460:1117-1121.
21. Dagenais T.R., Giles S.S., Aimanianda V., et al. Aspergillus fumigatus LaeA mediated phagocytosis is associated with a decreased hydrophobin layer. Infect Immun 2010, 78:823-829.
22. Roilides E., Dimitriadou-Georgiadou A., Sein T., Kadiltsoglou I., Walsh T.J. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998, 66:5999-6003.
23. Kawakami K., Qureshi M.H., Koguchi Y., Zhang T., Okamura H., Kurimoto M. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. Cell Immunol 1999, 193:9-16.
24. Gaviria J.M., van Burik J.A., Dale D.C., Root R.K., Liles W.C. Comparison of interferon gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999, 179:1038-1041.
25. Van Enckevort F.H.J., Netea M.G., Hermus A.R.M.M., Sweep C.G.J., Meis J.F.G.M., et al. Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol 1999, 37:419-426.
26. Romani L., Mencacci A., Cenci E., Spaccapelo R., Toniatti C., et al. Impaired neutrophil response and CD4(+) T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996, 183(1996):1345-1355.
27. Havell E.A., Sehgal P.B. Tumor necrosis factor independent IL-6 production during murine listeriosis. J Immunol 1991, 146:756-761.
28. Biffl W.L., Moore E., Moore F.A., Barnett C.C., Carl V.S., Peterson V.M. Interleukin-6 delays neutrophil apoptosis. Arch Surg 1996, 131:24-30.
29. Biffl W., Moore E.E., Moore F.A., Barnett C.C. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma 1996, 40(1996):575-579.